0000000001119374

AUTHOR

Aileen Bahl

showing 2 related works from this author

Hormone Replacement Therapy Associated White Blood Cell DNA Methylation and Gene Expression are Associated With Within-Pair Differences of Body Adipo…

2015

The loss of estrogen during menopause causes changes in the female body, with wide-ranging effects on health. Estrogen-containing hormone replacement therapy (HRT) leads to a relief of typical menopausal symptoms, benefits bone and muscle health, and is associated with tissue-specific gene expression profiles. As gene expression is controlled by epigenetic factors (including DNA methylation), many of which are environmentally sensitive, it is plausible that at least part of the HRT-associated gene expression is due to changes in DNA methylation profile. We investigated genome-wide DNA methylation and gene expression patterns of white blood cells (WBCs) and their associations with body compo…

medicine.medical_specialtyvaihdevuodetmedicine.drug_classHormone Replacement TherapyHRTmenopauseGene ExpressionBiologyBody fat percentageepigenetic regulationBody Mass IndexBone DensityInternal medicineGene expressionmedicineLeukocytesHumansgeeniekspressioEpigeneticsGeneGenetics (clinical)kehonkoostumusAdipositybody compositionta1184skeletal muscle compositionObstetrics and Gynecologyta3141DNA MethylationDNA-metylaatio3. Good healthPostmenopausehormone replacement therapyEndocrinologyDifferentially methylated regionsEstrogenPediatrics Perinatology and Child HealthDNA methylationLean body massFemalediscordant monozygotic twin pair designbone mineral contentGenome-Wide Association StudyTwin research and human genetics : the official journal of the International Society for Twin Studies
researchProduct

Genome-wide association analysis on normal hearing function identifies PCDH20 and SLC28A3 as candidates for hearing function and loss.

2015

Hearing loss and individual differences in normal hearing both have a substantial genetic basis. Although many new genes contributing to deafness have been identified, very little is known about genes/variants modulating the normal range of hearing ability. To fill this gap, we performed a two-stage meta-analysis on hearing thresholds (tested at 0.25, 0.5, 1, 2, 4, 8 kHz) and on pure-tone averages (low-, medium-and high-frequency thresholds grouped) in several isolated populations from Italy and Central Asia (total N = 2636). Here, we detected two genome-wide significant loci close to PCDH20 and SLC28A3 (top hits: rs78043697, P = 4.71E-10 and rs7032430, P = 2.39E-09, respectively). For both…

Genome-wide association studieLOCICOMMON DISEASESNerve Tissue ProteinsVARIANTSSUSCEPTIBILITYDeafnessGenome-wide association studiesMiceHearingGenome-wide association studies; normal hearing function; PCDH20; SLC28A3PCDH20SLC28A3otorhinolaryngologic diseasesAnimalsHumansGenetic Predisposition to DiseaseMETAANALYSISHair Cells Auditory InnerSequence Analysis RNAAssociation Studies ArticlesMembrane Transport ProteinsLOCALIZATIONCadherinsTRANSPORTER-3ProtocadherinsGENOTYPEMYOSIN-VIIAItalyAsia Centralnormal hearing function3111 BiomedicineGenome-Wide Association StudyHuman molecular genetics
researchProduct